CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC
SEC CIK 1864554 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LAB | STANDARD BIOTOOLS INC. | Dir | 72.10M | $2.05M | — | 2 | 2024-08-22 | 2025-12-02 |
Most active insiders at LAB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Casdin Partners GP, LLC | Dir, 10% | $11.41M | — |
| 2 | Casdin Eli | Dir, 10% | $1.37M | — |
| 3 | Casdin Partners Master Fund, L.P. | Dir, 10% | $1.12M | — |
| 4 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC | Dir | $503.0K | — |
| 5 | Kim Hanjoon Alex | CFO | — | — |
| 6 | Mackay Sean | SVP, Chief Business Off | — | — |
| 7 | Cox Troy | Dir | — | — |
| 8 | Carey Thomas D. | Dir | — | — |
| 9 | Egholm Michael | Pres, CEO, Dir | — | — |
| 10 | Witney Frank | Dir | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-12-04 | 2025-12-02+ | LAB | STANDARD BIOTOOLS INC. | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC | Dir | P - Purchase | $1.44 | +350.0K | 72.10M | +0.5% | +$503.0K |
| MI | 2024-08-26 | 2024-08-22+ | LAB | STANDARD BIOTOOLS INC. | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC | Dir | P - Purchase | $2.06 | +750.0K | 53.33M | +1% | +$1.55M |
Purchase Sale Sale after option exercise All abbreviations